Skip to main content
NVDA+0.21%AAPL-0.23%GOOGL+0.30%MSFT-0.42%AMZN-0.29%TSM+0.17%SPCX-4.21%META+0.03%AVGO+0.73%TSLA-0.15%BRK-B+0.61%SKHY-3.19%LLY-1.36%MU+0.27%AMD+1.90%WMT-0.71%JPM-0.86%V+1.74%XOM+1.12%ASMLa-4.20%JNJ-5.73%MA+1.63%INTC+1.44%0700.HK-0.03%ABBV-2.40%1398.HK-1.41%CSCO-0.23%CVX+1.27%COST-0.50%ORCL+4.23%KO+0.36%BAC-1.14%DELL-0.72%LRCX-2.73%AMAT-6.69%PG-0.10%AP2d-8.45%CAT-3.33%UNH-0.20%3988.HK-1.16%1816.HK-25.11%0005.HK-1.09%HSBA.L+0.17%0857.HK+0.29%GE-0.33%PM-1.34%0939.HK-1.63%1288.HK-2.19%MS-1.78%NFLX-0.21%CADCHF+0.61%GBPCHF+0.51%AUDCHF+0.47%NZDCHF+0.45%GBPTRY+0.41%USDCAD-0.41%EURCAD-0.36%CADJPY+0.34%AUDSGD+0.32%GBPHKD+0.32%GBPUSD+0.31%NZDSGD+0.31%NZDUSD+0.29%GBPMXN-0.28%AUDUSD+0.28%USDTRY+0.27%EURCHF+0.25%GBPJPY+0.25%CHFJPY-0.24%NZDMXN+0.23%USDNOK-0.23%EURGBP-0.23%AUDJPY+0.22%NZDJPY+0.21%USDZAR-0.21%GBPSGD+0.20%USDCHF+0.19%EURAUD-0.19%EURNZD-0.17%NOKJPY+0.17%USDSEK-0.17%CHFSGD+0.17%AUDDKK+0.16%USDILS+0.16%EURSGD+0.16%NZDCAD-0.16%USDPLN-0.16%AUDCAD-0.13%EURNOK-0.13%CHFNOK-0.12%SGDJPY-0.12%EURZAR-0.11%EURHKD+0.10%USDDKK-0.10%PLNJPY+0.10%GBPCAD-0.09%EURCNH+0.08%GBPZAR-0.08%EURUSD+0.07%EURSEK-0.06%CHFSEK-0.06%USDSGD+0.06%EURPLN-0.06%USDJPY-0.05%USDTHB+0.05%GBPAUD+0.05%USDCOP-0.04%AUDNOK+0.04%GBPNZD+0.03%USDCNH-0.02%USDMXN-0.02%EURJPY+0.02%AUDNZD+0.02%EURCZK+0.01%USDHKD+0.01%EURDKK0.00%HG1+0.79%COTTON+0.75%XNGUSD+0.42%S1+0.42%W1-0.28%XAGUSD+0.26%GAGUSD+0.25%UKOIL-0.19%USOIL-0.15%XAUUSD+0.13%GAUUSD+0.13%XPTUSD+0.08%BTCUSD+2.42%ETHUSD+17.67%USDTUSD+0.02%XRPUSD+11.86%SOLUSD+12.05%TRXUSDT+0.77%ZECUSDT+8.82%DOGEUSD+14.12%XMRUSDT+5.80%LINKUSD+13.42%XLMUSD+0.34%BCHUSDT+5.78%LTCUSD+9.66%UNIUSD+7.79%SUIUSD+3.65%HBARUSDT+0.48%TONUSD+26.15%TAOUSDT+3.98%AAVEUSD+3.78%DOTUSDT+0.06%ICPUSDT+0.82%ONDOUSDT+0.53%WLDUSDT+0.17%ARBUSDT+6.90%JUPUSDT+0.62%ATOMUSDT+1.84%INJUSDT+13.93%STXUSDT+5.78%FETUSDT+3.16%TIAUSDT+9.38%PYTHUSDT-0.47%SEIUSDT+4.57%IMXUSDT+0.63%OPUSDT+19.70%GRTUSDT+4.03%IOTAUSDT+1.15%WIFUSDT+2.70%AXSUSDT-1.74%POLUSDT+2.83%FARTCOINUSDT+0.81%EOSUSDT+2.46%DYDXUSDT+3.59%GALAUSDT-1.87%ORDIUSDT+0.06%RONINUSDT-3.42%NOTUSDT+1.21%NVDA+0.21%AAPL-0.23%GOOGL+0.30%MSFT-0.42%AMZN-0.29%TSM+0.17%SPCX-4.21%META+0.03%AVGO+0.73%TSLA-0.15%BRK-B+0.61%SKHY-3.19%LLY-1.36%MU+0.27%AMD+1.90%WMT-0.71%JPM-0.86%V+1.74%XOM+1.12%ASMLa-4.20%JNJ-5.73%MA+1.63%INTC+1.44%0700.HK-0.03%ABBV-2.40%1398.HK-1.41%CSCO-0.23%CVX+1.27%COST-0.50%ORCL+4.23%KO+0.36%BAC-1.14%DELL-0.72%LRCX-2.73%AMAT-6.69%PG-0.10%AP2d-8.45%CAT-3.33%UNH-0.20%3988.HK-1.16%1816.HK-25.11%0005.HK-1.09%HSBA.L+0.17%0857.HK+0.29%GE-0.33%PM-1.34%0939.HK-1.63%1288.HK-2.19%MS-1.78%NFLX-0.21%CADCHF+0.61%GBPCHF+0.51%AUDCHF+0.47%NZDCHF+0.45%GBPTRY+0.41%USDCAD-0.41%EURCAD-0.36%CADJPY+0.34%AUDSGD+0.32%GBPHKD+0.32%GBPUSD+0.31%NZDSGD+0.31%NZDUSD+0.29%GBPMXN-0.28%AUDUSD+0.28%USDTRY+0.27%EURCHF+0.25%GBPJPY+0.25%CHFJPY-0.24%NZDMXN+0.23%USDNOK-0.23%EURGBP-0.23%AUDJPY+0.22%NZDJPY+0.21%USDZAR-0.21%GBPSGD+0.20%USDCHF+0.19%EURAUD-0.19%EURNZD-0.17%NOKJPY+0.17%USDSEK-0.17%CHFSGD+0.17%AUDDKK+0.16%USDILS+0.16%EURSGD+0.16%NZDCAD-0.16%USDPLN-0.16%AUDCAD-0.13%EURNOK-0.13%CHFNOK-0.12%SGDJPY-0.12%EURZAR-0.11%EURHKD+0.10%USDDKK-0.10%PLNJPY+0.10%GBPCAD-0.09%EURCNH+0.08%GBPZAR-0.08%EURUSD+0.07%EURSEK-0.06%CHFSEK-0.06%USDSGD+0.06%EURPLN-0.06%USDJPY-0.05%USDTHB+0.05%GBPAUD+0.05%USDCOP-0.04%AUDNOK+0.04%GBPNZD+0.03%USDCNH-0.02%USDMXN-0.02%EURJPY+0.02%AUDNZD+0.02%EURCZK+0.01%USDHKD+0.01%EURDKK0.00%HG1+0.79%COTTON+0.75%XNGUSD+0.42%S1+0.42%W1-0.28%XAGUSD+0.26%GAGUSD+0.25%UKOIL-0.19%USOIL-0.15%XAUUSD+0.13%GAUUSD+0.13%XPTUSD+0.08%BTCUSD+2.42%ETHUSD+17.67%USDTUSD+0.02%XRPUSD+11.86%SOLUSD+12.05%TRXUSDT+0.77%ZECUSDT+8.82%DOGEUSD+14.12%XMRUSDT+5.80%LINKUSD+13.42%XLMUSD+0.34%BCHUSDT+5.78%LTCUSD+9.66%UNIUSD+7.79%SUIUSD+3.65%HBARUSDT+0.48%TONUSD+26.15%TAOUSDT+3.98%AAVEUSD+3.78%DOTUSDT+0.06%ICPUSDT+0.82%ONDOUSDT+0.53%WLDUSDT+0.17%ARBUSDT+6.90%JUPUSDT+0.62%ATOMUSDT+1.84%INJUSDT+13.93%STXUSDT+5.78%FETUSDT+3.16%TIAUSDT+9.38%PYTHUSDT-0.47%SEIUSDT+4.57%IMXUSDT+0.63%OPUSDT+19.70%GRTUSDT+4.03%IOTAUSDT+1.15%WIFUSDT+2.70%AXSUSDT-1.74%POLUSDT+2.83%FARTCOINUSDT+0.81%EOSUSDT+2.46%DYDXUSDT+3.59%GALAUSDT-1.87%ORDIUSDT+0.06%RONINUSDT-3.42%NOTUSDT+1.21%
AT

ADC Therapeutics S.A. (ADCT)

NYSE • Healthcare

$1.7
-$0.16 (-8.6%)
Market closed

Last close at October 13, 2026 at 20:00 UTC

Open$1.83
Day Range$1.63 - $1.86
Avg. Volume (3M)1.8M
Market Cap$216.2M
52 Week Range
$0.78$4.98
Next EarningsIn 27 daysNov 10, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$19.2M100%
Gross Profitminus cost of goods$16.8M88%

In plain terms: out of every $100 in revenue, ADC Therapeutics S.A. currently loses $86.

Fundamentals & Financials

Revenue (TTM)
$78.7M
Net Income (TTM)
-$96.9M
EPS (TTM)
-$0.66
ROA (TTM)
-34.69%
Current Ratio
3.03

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+87.5%Q1 2026-$0.04
-10.5%Q2 2026-$0.21
+49.1%Q3 2026-$0.11
Next

Nov 10

in 27 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +49.1%

ADC Therapeutics beat consensus on both revenue and earnings in the second fiscal quarter of 2026, reported Aug. 13, as revenue rose 2.2% to about $19.2 million and EPS was -$0.11 versus a -$0.22 estimate, +49%. Gross profit reached about $16.9 million, with gross margin near 88%, while operating loss was about $25.4 million and operating margin was around -132%. Net income improved 70.8% to about -$16.6 million from about -$56.6 million a year earlier, and EPS improved from -$0.50. Operating cash flow was negative about $11.8 million. Consensus for the next period calls for EPS of -$0.21 on revenue of $18.9 million.

Next report — what to expect

ADC Therapeutics S.A. (ADCT) reports earnings on November 10, 2026. Wall Street is looking for EPS of -$0.21 on revenue of $18.7 million. For trailing context, revenue increased +2.2% year over year last quarter. ADCT has beaten EPS in 5 of 8 most recent quarters, making profit/loss and topline delivery key watch items.

View full earnings history

About ADC Therapeutics S.A.

ADC Therapeutics S.A. develops antibody-drug conjugates for blood cancers and solid tumors, placing it in the biotechnology part of healthcare. Listed on the NYSE as ADCT, it records $81.4 million of revenue in FY2025, centered on ZYNLONTA and a pipeline of oncology candidates.

Name
ADC Therapeutics S.A.
CEO
Ameet Mallik
Website
www.adctherapeutics.com
Industry
Healthcare
Year Founded
2011
Employees
191

Today's Snapshot

AI-generated

The day ended with ADCT 8.6% lower at 1.70, in line with a weaker sector. Trading was busier than usual, with volume about half as much again as its usual level.

Trading Volume

Above 10d avg 2.2M

3.3M

vs S&P 500 Today

Strong Underperformance

-8.58%

Updated: October 13, 2026 at 20:28 UTC

Technical Indicators

5 Buy1 Neutral2 Sell
ADCT shows constructive short-to-medium trend with the price trading above its 10–100 day moving averages while remaining below the 200-day, and the ADX near 26 suggests a moderate trend. Momentum indicators are mixed: RSI sits in bullish territory near the mid-60s and CCI is strongly positive, while Stochastic is stretched which tempers the strength. MACD is positive, supporting the short-term bias, and ATR is elevated at roughly 8.5% indicating larger intraday swings. On-balance volume is negative, suggesting limited volume confirmation of the move. Technical takeaway: Buy.
All signals
  • EMA (5 indicators)$1.32 - $2.49
    Buy
  • RSI (14)67.08
    Neutral
  • Stochastic %K (14, 3, 3)88.26
    Sell
  • MACD Level (12, 26)0.13
    Buy

Peers & Related Assets

OMEROmeros Corporation
$18.88-3.8%
ALMSAlumis Inc.
$6.56-7.1%
FDMT4D Molecular Therapeutics, Inc.
$12.36-4.9%
QSIQuantum-Si incorporated
$1.41+3.7%
RAPTRAPT Therapeutics, Inc.
LXRXLexicon Pharmaceuticals, Inc.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.